An elastomeric material is disclosed, which is suitable, in particular, as a sealing material between the fuel cells of a fuel cell stack and the stacks as such, wherein the hybrid elastomeric material includes a hybrid elastomer with a proportion of a siloxane polymeric material and a proportion of a polyolefin elastomeric material, wherein the two materials are crosslinked with one another by addition. Further aspects relate to polyelectrolyte fuel cells, which include sealing elements made of the hybrid elastomeric material, as well as the use of the hybrid elastomeric material in a screen printing process.

The present invention provides a liquid polysiloxane comprising a siloxane-thiourea segment and a crosslinkable functional group(s) selected from one or more ethylenically unsaturated groups, silyl hydride groups, alkylenethiol groups and combinations thereof.

The present invention provides a liquid polysiloxane comprising a siloxane-thiourea segment and a crosslinkable functional group(s) selected from one or more ethylenically unsaturated groups, silyl hydride groups, alkylenethiol groups and combinations thereof.

A rubber composition includes a silicone rubber and a conductive filler. The content of the conductive filler in the rubber composition is 0.5 to 5 volume %. The conductive filler contains carbon nanotubes having a length of greater than 5 μm The radius of gyration which is determined by subjecting the rubber composition to ultra-small angle X-ray scattering to obtain a scattering curve, and analyzing the scattering curve with the Beaucage model is 40 nm to 300 nm.

A rubber composition includes a silicone rubber and a conductive filler. The content of the conductive filler in the rubber composition is 0.5 to 5 volume %. The conductive filler contains carbon nanotubes having a length of greater than 5 μm The radius of gyration which is determined by subjecting the rubber composition to ultra-small angle X-ray scattering to obtain a scattering curve, and analyzing the scattering curve with the Beaucage model is 40 nm to 300 nm.

Provided are both a superabsorbent polymer capable of continuously and safely exhibiting an improved bacterial growth inhibitory property and a deodorant property without deterioration in the physical properties of the superabsorbent polymer, such as water retention capacity, absorption under pressure, etc., as well as a preparation method for the superabsorbent polymer.

Curable adhesive compositions are provided that can be cured using ultraviolet or visible light radiation. These curable adhesive compositions, which contain a curable (meth)acrylate copolymer, have a creep compliance that is less than 5(10.sup.−4) inverse Pascals at 25° C., a creep compliance that is greater than 1(10.sup.−3) inverse Pascals at 70° C., and a shear storage modulus greater than 40 kiloPascals when measured at 25° C. at a frequency of 1 radian/second.

Curable adhesive compositions are provided that can be cured using ultraviolet or visible light radiation. These curable adhesive compositions, which contain a curable (meth)acrylate copolymer, have a creep compliance that is less than 5(10.sup.−4) inverse Pascals at 25° C., a creep compliance that is greater than 1(10.sup.−3) inverse Pascals at 70° C., and a shear storage modulus greater than 40 kiloPascals when measured at 25° C. at a frequency of 1 radian/second.

Disclosed herein compositions of polysaccharides chemically cross-linked by aromatic dialdehydes. The compositions may be in form of polymeric sheets for a variety of applications. Disclosed also nano-sized particles comprising the polysaccharide chemically cross-linked by aromatic dialdehydes. The nano-sized particles may further comprise lipids and surfactants. Intranasal delivery of the nano-sized particles enables delivery of biologically active agents into the brain. Topical and transdermal delivery of the nano-sized particles enables delivery of biologically active agents for treatment of systemic or dermatological disorders. Methods of manufacturing and uses of the compositions are also disclosed.

In various exemplary embodiments, the present disclosure provides organohydrogel fibers and a process for making the organohydrogel fibers. The organohydrogel fibers have a hydrophobic phase dispersed in a hydrophilic phase. The organohydrogel fibers contain at least one hydrophobic active pharmaceutical ingredient (API), and at least one hydrophilic API. The organohydrogel fibers can be formed into a non-woven or 3D printed patch and a replaceable backing can be attached to the patch to make an effective wound dressing. The wound dressing can deliver active pharmaceutical ingredients to the wound over a period of multiple days.